Glycomine
Developer of orphan drugs designed to treat rare disorders of metabolism and protein misfolding. The company's drugs combine replacement therapies such as substrates, enzymes, and proteins with intrac...
Valuation
$220M
Market implied
Share Price
N/A
Total Raised
$195.6M
Last Round
N/A